2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Neurodermatitis: new trials by email Literature Review of Neurodermatitis trials Research Report on Neurodermatitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases KPL-716, Placebo - Chronic Idiopathic Urticaria, Chronic Idiopathic Pruritus | Phase 2 | Completed | Genentech, Inc. | 58 | 2019-05-29 | 2025-03-18 |
| Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis Secukinumab 300 mg, Placebo - Dermatitis, Atopic, Eczema, Atopic | Phase 2 | Completed | GWT-TUD GmbH | 22 | 2018-09-18 | 2021-05-03 |
Chronic Urticaria (1) · Dermatitis, Atopic (1) · Lichen Planus (1) · Pruritus (1) · Skin and Connective Tissue Diseases (1)
Dermatitis (2) · Hypersensitivity (2) · Hypersensitivity, Immediate (2) · Immune System Diseases (2) · Skin Diseases (2) · Skin Diseases, Eczematous (2) · Chronic Disease (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Disease Attributes (1) · Genetic Diseases, Inborn (1) · Lichenoid Eruptions (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Skin Diseases, Genetic (1)
secukinumab (1)
GWT-TUD GmbH (1) · Genentech, Inc. (1)
Germany (1) · United States (1)
Stefan Beissert, Prof. Dr. (1)
2016 (1)